The “gamma gap” or globulins, i.e. the difference between total serum proteins and albumin measured from a comprehensive metabolic panel, is a frequently used clinical screening tool to assess for latent infection, malignancy, or autoimmune inflammatory diseases [1–4]. This evidence concerns the gene ALB and disease arising from reactivation of latent virus.